ProfileGDS5822 / ILMN_2751587
TitleAnti-CTLA-4 immunotherapy effect on αSMA+ myofibroblast late-depleted pancreatic ductal adenocarcinoma model
OrganismMus musculus


control myofibroblast depletion untreated anti-CTLA4 antibody GSM1276599 GSM1276600 GSM1276601 GSM1276602 GSM1276603 GSM1276604 GSM1303940 GSM1303941 GSM1303942 86% 87% 84% 86% 86% 86% 84% 86% 87% sort by protocol sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM1276599PDAC Late Ablation Control 1274.586
GSM1276600PDAC Late Ablation Control 2330.387
GSM1276601PDAC Late Ablation Control 3306.884
GSM1276602PDAC Late Ablation 1278.386
GSM1276603PDAC Late Ablation 2298.486
GSM1276604PDAC Late Ablation 3311.386
GSM1303940PDAC Late Ablation_anti-CTLA4 1225.484
GSM1303941PDAC Late Ablation_anti-CTLA4 2364.686
GSM1303942PDAC Late Ablation_anti-CTLA4 3419.887